Skip to main content

Table 2 Survival rate after neoadjuvant chemotherapy for advanced adenocarcinoma

From: The role of neoadjuvant and adjuvant treatment for adenocarcinoma of the upper gastrointestinal tract

Study Adeno-carcinoma n (%) Survival CHX + Surgery Survival Surgery p- value
MRC, 2002 [9] 528 (66%) 32% 25% 0.02
   (3 y) (3 y)  
MAGIC, 2006 [10] 503 (100% dist. 36.3% 23% 0.009
  esophagus and stomach) (5 y) (5 y)  
FFCD, 2007 [11] 226 (100% dist. 38% 24% 0.021
  esophagus and stomach) (5 y) (5 y)  
  1. CHX = chemotherapy, y = years